Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Netropsin improves survival from endotoxaemia by disrupting HMGA1 binding to the NOS2 promoter.

Grant MA, Baron RM, Macias AA, Layne MD, Perrella MA, Rigby AC.

Biochem J. 2009 Feb 15;418(1):103-12. doi: 10.1042/BJ20081427.

2.

Reduction of nitric oxide synthase 2 expression by distamycin A improves survival from endotoxemia.

Baron RM, Carvajal IM, Liu X, Okabe RO, Fredenburgh LE, Macias AA, Chen YH, Ejima K, Layne MD, Perrella MA.

J Immunol. 2004 Sep 15;173(6):4147-53.

3.

Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.

Baron RM, Lopez-Guzman S, Riascos DF, Macias AA, Layne MD, Cheng G, Harris C, Chung SW, Reeves R, von Andrian UH, Perrella MA.

PLoS One. 2010 May 14;5(5):e10656. doi: 10.1371/journal.pone.0010656.

4.

Elk-3 is a transcriptional repressor of nitric-oxide synthase 2.

Chen YH, Layne MD, Chung SW, Ejima K, Baron RM, Yet SF, Perrella MA.

J Biol Chem. 2003 Oct 10;278(41):39572-7. Epub 2003 Jul 31.

5.
6.
8.

Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2.

Chiefari E, Arcidiacono B, Possidente K, Iiritano S, Ventura V, Pandolfo R, Brunetti FS, Greco M, Foti D, Brunetti A.

PLoS One. 2013 Dec 18;8(12):e83969. doi: 10.1371/journal.pone.0083969. eCollection 2013.

9.
10.

Transcriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1).

Bianconcini A, Lupo A, Capone S, Quadro L, Monti M, Zurlo D, Fucci A, Sabatino L, Brunetti A, Chiefari E, Gottesman ME, Blaner WS, Colantuoni V.

Int J Biochem Cell Biol. 2009 Nov;41(11):2189-203. doi: 10.1016/j.biocel.2009.04.011. Epub 2009 Apr 21.

11.
12.

Identification of hamster inducible nitric oxide synthase (iNOS) promoter sequences that influence basal and inducible iNOS expression.

Saldarriaga OA, Travi BL, Choudhury GG, Melby PC.

J Leukoc Biol. 2012 Jul;92(1):205-18. doi: 10.1189/jlb.1010568. Epub 2012 Apr 18.

13.

High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer.

Perrella MA, Pellacani A, Wiesel P, Chin MT, Foster LC, Ibanez M, Hsieh CM, Reeves R, Yet SF, Lee ME.

J Biol Chem. 1999 Mar 26;274(13):9045-52.

14.

High mobility group A1 protein mediates human nitric oxide synthase 2 gene expression.

Takamiya R, Baron RM, Yet SF, Layne MD, Perrella MA.

FEBS Lett. 2008 Mar 5;582(5):810-4. doi: 10.1016/j.febslet.2008.02.008. Epub 2008 Feb 13.

15.

High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2).

Battista S, Fedele M, Martinez Hoyos J, Pentimalli F, Pierantoni GM, Visone R, De Martino I, Croce CM, Fusco A.

Biochem J. 2005 Jul 1;389(Pt 1):91-7.

16.
17.

RNA-Mediated Regulation of HMGA1 Function.

Benecke AG, Eilebrecht S.

Biomolecules. 2015;5(2):943-57. Review.

18.
19.

Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-beta1.

Pellacani A, Wiesel P, Razavi S, Vasilj V, Feinberg MW, Chin MT, Reeves R, Perrella MA.

J Biol Chem. 2001 Jan 12;276(2):1653-9.

20.

A novel role for Oct-2 in the lipopolysaccharide-mediated induction of resistin gene expression in RAW264.7 cells.

Lu SC, Chang SF, Chen HL, Chou YY, Lan YH, Chuang CY, Yu WH, Chen CL.

Biochem J. 2007 Mar 1;402(2):387-95.

Items per page

Supplemental Content

Write to the Help Desk